Ajay Samkaria/LinkedIn
Jun 9, 2026, 17:53
Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
Ajay Samkaria, Product and Application Manager at DIAGAST, shared a post on LinkedIn:
“ABO subgroups are more than just laboratory curiosities—they are clinically significant and can directly impact transfusion safety.
Weak or variant antigen expressions may lead to blood grouping discrepancies, incompatible transfusions, and delayed clinical decisions if not properly identified.
Highlights:
- Classification of A, B and O subgroups.
- Bombay (Oh) and Para Bombay phenotypes.
- Rare phenotypes such as INA and INB.
- Clinical and immunohematological significance.
- Common methods for subgroup confirmation.
Accurate detection and confirmation of ABO subgroups remain essential for safe transfusion practice and quality immunohematology reporting.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?